Lorundrostat is an orally-administered highly selective aldosterone synthase inhibitor that reduces aldosterone levels by inhibiting CYP11B2. The Launch-HTN trial (ClinicalTrials.gov Identifier: ...
The trial of the once-daily drug—which mimics a gut hormone known as GLP-1 to control blood sugar and suppress ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback